Your session is about to expire
← Back to Search
Letrozole + GnRH Antagonist for Healthy Subjects
Study Summary
This trial is looking at the effects of two drugs, letrozole and NAL-GLU GnRH antagonist, on women's hormone levels. The purpose is to study how the drugs affect the menstrual cycle and fertility.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 79 Patients • NCT02137538Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You should be in good physical and mental health overall.I have a history of liver or kidney disease.My cancer is hormone-receptor positive.I do not have high levels of male hormones.I haven't taken any medications, including hormones, for 3 months.My liver function tests are normal.I do not have high levels of male hormones.I am using reliable birth control or am not sexually active during the study.I am between 18 and 35 years old.I haven't taken any medications, including hormones, for the last 3 months.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Aromatase inhibitor EFP
- Group 2: Aromatase inhibitor LFP
Frequently Asked Questions
What does the scientific community know about Letrozole from other research?
"As of right now, 211 clinical trials are underway that involve Letrozole. Of those, 55 are in the critical Phase 3 stage. Most of the research is being conducted in San Francisco, but there are 13744 active trial sites across America."
How many people are signing up to participate in this research?
"Unfortunately, this study is no longer enrolling patients. Although, if you are seeking other clinical trials, 895 studies are admitting healthy subjects and 211 trials are recruiting for Letrozole specifically."
What is the common purpose of Letrozole?
"While letrozole is most often prescribed to treat breast cancer, it can also be used as part of anovulatory cycle therapy, tamoxifen treatment, and ovulation induction therapy."
Are patients currently being recruited for this research?
"The clinical trial in question was last updated over 3 years ago, meaning it is not currently recruiting patients. However, there are 1106 other trials that are still open to participants."
Does this research allow for volunteers that are senior citizens?
"The age range that is eligible for this trial starts at 18 and ends at 40 years old."
To whom does this trial grant access?
"The ideal applicant for this clinical trial would be a healthy woman aged 18-40 who has not been taking any medications, including hormonal drugs, for at least 3 months. Additionally, she should have regular menstrual cycles every 25-35 days with ovulation confirmed by luteal phase progesterone levels >3 ng/ml. There should also be no evidence of androgen excess, normal TSH, prolactin and hemoglobin levels, and the use of double-barrier contraception is necessary. Finally, the woman must have a negative pregnancy test (serum) at the beginning of each cycle of study and normal liver function test"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger